Insider Transactions in Q1 2025 at Oramed Pharmaceuticals Inc. (ORMP)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 11
2025
|
Avraham Gabay Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
76,000
+8.4%
|
-
|
|
Feb 11
2025
|
Nadav Kidron President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
427,000
+5.28%
|
-
|
|
Feb 11
2025
|
Joshua Hexter COO & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
126,834
+5.07%
|
-
|
|
Feb 11
2025
|
Miriam Kidron Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
192,667
+5.38%
|
-
|
|
Jan 02
2025
|
Joshua Hexter COO & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
194,500
+21.59%
|
-
|
|
Jan 02
2025
|
Miriam Kidron Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
207,000
+17.14%
|
-
|
|
Jan 02
2025
|
Avraham Gabay Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
188,000
+34.43%
|
-
|
|
Jan 02
2025
|
Nadav Kidron President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
433,500
+16.1%
|
-
|